Alimentary Health Ltd   Report issue

For profit Phase 3
Founded: Cork Ireland (1999)
Status: Left NME R&D (2018)

Organization Overview

First Clinical Trial
2004
NCT00135031
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

bifidobacterium infantis (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Irritable Bowel Syndrome (Phase 3)

Psoriasis (Phase 2)

Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 1